Created in 2012 (United States), AngiogenesisMAP own 28 sister brands and 2617 competing brands. The AngiogenesisMAP brand is owned by Myriad Genetics, a company listed in New York. AngiogenesisMAP is part of the Medical Diagnostics & Research activity sector.
Share price and profitability of the share Myriad Genetics (AngiogenesisMAP)
Buy Myriad Genetics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Myriad Genetics
(AngiogenesisMAP)
over 5 years*
USD 10.29
Stock market history Myriad Genetics (AngiogenesisMAP)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
